APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Tumor Screening Services

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pet Tumor Screening Services Industry Growth and Trends Forecast to 2032

4 June 2026112 pages

Choose your research edition.

Industry ResearchPet Tumor Screening Services Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Tumor Screening Services Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Pet Tumor Screening Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Tumor Screening Services Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Tumor Screening Services Market Analysis and Forecast 2026-2032231 pages · $4,950 USD

Market perspective

According to APO Research, the global Pet Tumor Screening Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pet Tumor Screening Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pet Tumor Screening Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Tumor Screening Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Pet Tumor Screening Services market include PetDx, CYTOGEN, BioChain, Small Door, ANGLE, BioChain Institute Inc., CANCAN DIAGNOSTICS., IDEXX Laboratories and Zoetis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pet Tumor Screening Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pet Tumor Screening Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pet Tumor Screening Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pet Tumor Screening Services.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Pet Tumor Screening Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pet Tumor Screening Services Market by Company

PetDx

CYTOGEN

BioChain

Small Door

ANGLE

BioChain Institute Inc.

CANCAN DIAGNOSTICS.

IDEXX Laboratories

Zoetis

VCA Animal Hospitals

AniCura

Anicom Holdings

Tokyo Pet Medical Center

Qiming Pet Hospital

RuiPai Pet

IDK Animal Diagnostics

Beijing Pet Medical Center

Baili Pet Health

Pet Tumor Screening Services Segment by Type

Cut Biopsy

Needle Biopsy

Pet Tumor Screening Services Segment by Application

Pet Hospital

Clinic

Scientific Research Institutions

Pet Tumor Screening Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Tumor Screening Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Tumor Screening Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Tumor Screening Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Pet Tumor Screening Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Pet Tumor Screening Services Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Pet Tumor Screening Services Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Pet Tumor Screening Services Market Share by Region (2021-2026) Table 4. Global Pet Tumor Screening Services Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Pet Tumor Screening Services Market Share by Region (2027-2032) Table 6. Global Pet Tumor Screening Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Pet Tumor Screening Services Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Pet Tumor Screening Services Market Size Share by Type (2021-2026) Table 9. Global Pet Tumor Screening Services Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Pet Tumor Screening Services Market Size Share Forecasted by Type (2027-2032) Table 11. North America Pet Tumor Screening Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Pet Tumor Screening Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Pet Tumor Screening Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Pet Tumor Screening Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Pet Tumor Screening Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Pet Tumor Screening Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Pet Tumor Screening Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Pet Tumor Screening Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Pet Tumor Screening Services Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Pet Tumor Screening Services Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Pet Tumor Screening Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Pet Tumor Screening Services Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Pet Tumor Screening Services Market Size Share by Application (2021-2026) Table 24. Global Pet Tumor Screening Services Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Pet Tumor Screening Services Market Size Share Forecasted by Application (2027-2032) Table 26. North America Pet Tumor Screening Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Pet Tumor Screening Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Pet Tumor Screening Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Pet Tumor Screening Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Pet Tumor Screening Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Pet Tumor Screening Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Pet Tumor Screening Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Pet Tumor Screening Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Pet Tumor Screening Services Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Pet Tumor Screening Services Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Pet Tumor Screening Services Industry Trends Table 37. Pet Tumor Screening Services Industry Drivers Table 38. Pet Tumor Screening Services Industry Opportunities and Challenges Table 39. Pet Tumor Screening Services Industry Restraints Table 40. Global Pet Tumor Screening Services Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Pet Tumor Screening Services Revenue Market Share by Company (2021-2026) Table 42. Global Pet Tumor Screening Services Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Pet Tumor Screening Services Key Company Headquarters & Area Served Table 44. Global Pet Tumor Screening Services Company, Product Type & Application Table 45. Global Pet Tumor Screening Services Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Pet Tumor Screening Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. PetDx Company Information Table 49. PetDx Business Overview Table 50. PetDx Pet Tumor Screening Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. PetDx Pet Tumor Screening Services Product Portfolio Table 52. PetDx Recent Development Table 53. CYTOGEN Company Information Table 54. CYTOGEN Business Overview Table 55. CYTOGEN Pet Tumor Screening Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. CYTOGEN Pet Tumor Screening Services Product Portfolio Table 57. CYTOGEN Recent Development Table 58. BioChain Company Information Table 59. BioChain Business Overview Table 60. BioChain Pet Tumor Screening Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. BioChain Pet Tumor Screening Services Product Portfolio Table 62. BioChain Recent Development Table 63. Small Door Company Information Table 64. Small Door Business Overview Table 65. Small Door Pet Tumor Screening Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Small Door Pet Tumor Screening Services Product Portfolio Table 67. Small Door Recent Development Table 68. ANGLE Company Information Table 69. ANGLE Business Overview Table 70. ANGLE Pet Tumor Screening Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. ANGLE Pet Tumor Screening Services Product Portfolio Table 72. ANGLE Recent Development Table 73. BioChain Institute Inc. Company Information Table 74. BioChain Institute Inc. Business Overview Table 75. BioChain Institute Inc. Pet Tumor Screening Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. BioChain Institute Inc. Pet Tumor Screening Services Product Portfolio Table 77. BioChain Institute Inc. Recent Development Table 78. CANCAN DIAGNOSTICS. Company Information Table 79. CANCAN DIAGNOSTICS. Business Overview Table 80. CANCAN DIAGNOSTICS. Pet Tumor Screening Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. CANCAN DIAGNOSTICS. Pet Tumor Screening Services Product Portfolio Table 82. CANCAN DIAGNOSTICS. Recent Development Table 83. IDEXX Laboratories Company Information Table 84. IDEXX Laboratories Business Overview Table 85. IDEXX Laboratories Pet Tumor Screening Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. IDEXX Laboratories Pet Tumor Screening Services Product Portfolio Table 87. IDEXX Laboratories Recent Development Table 88. Zoetis Company Information Table 89. Zoetis Business Overview Table 90. Zoetis Pet Tumor Screening Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Zoetis Pet Tumor Screening Services Product Portfolio Table 92. Zoetis Recent Development Table 93. VCA Animal Hospitals Company Information Table 94. VCA Animal Hospitals Business Overview Table 95. VCA Animal Hospitals Pet Tumor Screening Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. VCA Animal Hospitals Pet Tumor Screening Services Product Portfolio Table 97. VCA Animal Hospitals Recent Development Table 98. AniCura Company Information Table 99. AniCura Business Overview Table 100. AniCura Pet Tumor Screening Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. AniCura Pet Tumor Screening Services Product Portfolio Table 102. AniCura Recent Development Table 103. Anicom Holdings Company Information Table 104. Anicom Holdings Business Overview Table 105. Anicom Holdings Pet Tumor Screening Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Anicom Holdings Pet Tumor Screening Services Product Portfolio Table 107. Anicom Holdings Recent Development Table 108. Tokyo Pet Medical Center Company Information Table 109. Tokyo Pet Medical Center Business Overview Table 110. Tokyo Pet Medical Center Pet Tumor Screening Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Tokyo Pet Medical Center Pet Tumor Screening Services Product Portfolio Table 112. Tokyo Pet Medical Center Recent Development Table 113. Qiming Pet Hospital Company Information Table 114. Qiming Pet Hospital Business Overview Table 115. Qiming Pet Hospital Pet Tumor Screening Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Qiming Pet Hospital Pet Tumor Screening Services Product Portfolio Table 117. Qiming Pet Hospital Recent Development Table 118. RuiPai Pet Company Information Table 119. RuiPai Pet Business Overview Table 120. RuiPai Pet Pet Tumor Screening Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. RuiPai Pet Pet Tumor Screening Services Product Portfolio Table 122. RuiPai Pet Recent Development Table 123. IDK Animal Diagnostics Company Information Table 124. IDK Animal Diagnostics Business Overview Table 125. IDK Animal Diagnostics Pet Tumor Screening Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. IDK Animal Diagnostics Pet Tumor Screening Services Product Portfolio Table 127. IDK Animal Diagnostics Recent Development Table 128. Beijing Pet Medical Center Company Information Table 129. Beijing Pet Medical Center Business Overview Table 130. Beijing Pet Medical Center Pet Tumor Screening Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Beijing Pet Medical Center Pet Tumor Screening Services Product Portfolio Table 132. Beijing Pet Medical Center Recent Development Table 133. Baili Pet Health Company Information Table 134. Baili Pet Health Business Overview Table 135. Baili Pet Health Pet Tumor Screening Services Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Baili Pet Health Pet Tumor Screening Services Product Portfolio Table 137. Baili Pet Health Recent Development Table 138. North America Pet Tumor Screening Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Pet Tumor Screening Services Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Pet Tumor Screening Services Market Share by Country (2021-2026) Table 141. North America Pet Tumor Screening Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Pet Tumor Screening Services Market Share Forecast by Country (2027-2032) Table 143. Europe Pet Tumor Screening Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Pet Tumor Screening Services Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Pet Tumor Screening Services Market Share by Country (2021-2026) Table 146. Europe Pet Tumor Screening Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Pet Tumor Screening Services Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Pet Tumor Screening Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Pet Tumor Screening Services Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Pet Tumor Screening Services Market Share by Country (2021-2026) Table 151. Asia-Pacific Pet Tumor Screening Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Pet Tumor Screening Services Market Share Forecast by Country (2027-2032) Table 153. Latin America Pet Tumor Screening Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Pet Tumor Screening Services Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Pet Tumor Screening Services Market Share by Country (2021-2026) Table 156. Latin America Pet Tumor Screening Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Pet Tumor Screening Services Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Pet Tumor Screening Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Pet Tumor Screening Services Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Pet Tumor Screening Services Market Share by Country (2021-2026) Table 161. Middle East & Africa Pet Tumor Screening Services Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Pet Tumor Screening Services Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Pet Tumor Screening Services Product Image Figure 3. Global Pet Tumor Screening Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Pet Tumor Screening Services Market Size (2021-2032) & (US$ Million) Figure 5. Global Pet Tumor Screening Services Market Share by Region: 2025 VS 2032 Figure 6. Global Pet Tumor Screening Services Market Share by Region (2021-2032) Figure 7. North America Pet Tumor Screening Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Pet Tumor Screening Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Pet Tumor Screening Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Pet Tumor Screening Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Pet Tumor Screening Services Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Cut Biopsy Image Figure 13. Global Cut Biopsy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Needle Biopsy Image Figure 15. Global Needle Biopsy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Pet Tumor Screening Services Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Pet Tumor Screening Services Market Share by Type 2025 VS 2032 Figure 18. North America Pet Tumor Screening Services Market Size Share by Type (2021-2032) Figure 19. Europe Pet Tumor Screening Services Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Pet Tumor Screening Services Market Size Share by Type (2021-2032) Figure 21. Latin America Pet Tumor Screening Services Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Pet Tumor Screening Services Market Size Share by Type (2021-2032) Figure 23. Pet Hospital Image Figure 24. Global Pet Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Clinic Image Figure 26. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Scientific Research Institutions Image Figure 28. Global Scientific Research Institutions Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Pet Tumor Screening Services Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Pet Tumor Screening Services Market Share by Application 2025 VS 2032 Figure 31. North America Pet Tumor Screening Services Market Size Share by Application (2021-2032) Figure 32. Europe Pet Tumor Screening Services Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Pet Tumor Screening Services Market Size Share by Application (2021-2032) Figure 34. Latin America Pet Tumor Screening Services Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Pet Tumor Screening Services Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Pet Tumor Screening Services Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Pet Tumor Screening Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Pet Tumor Screening Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Pet Tumor Screening Services Market Share by Country (2021-2032) Figure 41. Europe Pet Tumor Screening Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Pet Tumor Screening Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Pet Tumor Screening Services Market Share by Country (2021-2032) Figure 44. Asia-Pacific Pet Tumor Screening Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Pet Tumor Screening Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Pet Tumor Screening Services Market Share by Country (2021-2032) Figure 47. Latin America Pet Tumor Screening Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Pet Tumor Screening Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Pet Tumor Screening Services Market Share by Country (2021-2032) Figure 50. Middle East & Africa Pet Tumor Screening Services Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Pet Tumor Screening Services Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Pet Tumor Screening Services Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Cut Biopsy
  • Needle Biopsy
Applications
  • Pet Hospital
  • Clinic
  • Scientific Research Institutions
Companies covered
  • PetDx
  • CYTOGEN
  • BioChain
  • Small Door
  • ANGLE
  • BioChain Institute Inc.
  • CANCAN DIAGNOSTICS.
  • IDEXX Laboratories
  • Zoetis
  • VCA Animal Hospitals
  • AniCura
  • Anicom Holdings
  • Tokyo Pet Medical Center
  • Qiming Pet Hospital
  • RuiPai Pet
  • IDK Animal Diagnostics
  • Beijing Pet Medical Center
  • Baili Pet Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Pet Tumor Screening Services Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Pet Tumor Screening Services Market Size by Region (2021-2032)
  5. 1.4.1 Global Pet Tumor Screening Services Market Size by Region (2021-2026)
  6. 1.4.2 Global Pet Tumor Screening Services Market Size by Region (2027-2032)
  7. 1.5 Key Regions Pet Tumor Screening Services Market Size (2021-2032)
  8. 1.5.1 North America Pet Tumor Screening Services Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Pet Tumor Screening Services Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Pet Tumor Screening Services Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Pet Tumor Screening Services Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Pet Tumor Screening Services Market Size Growth Rate (2021-2032)
2 Pet Tumor Screening Services Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Cut Biopsy
  3. 2.1.2 Needle Biopsy
  4. 2.2 Global Pet Tumor Screening Services Market Size by Type
  5. 2.2.1 Global Pet Tumor Screening Services Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Pet Tumor Screening Services Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Pet Tumor Screening Services Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Pet Tumor Screening Services Market Size by Regions
  9. 2.3.1 North America Pet Tumor Screening Services Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Pet Tumor Screening Services Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Pet Tumor Screening Services Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Pet Tumor Screening Services Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Pet Tumor Screening Services Market Size Breakdown by Type (2021-2026)
3 Pet Tumor Screening Services Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pet Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Scientific Research Institutions
  5. 3.2 Global Pet Tumor Screening Services Market Size by Application
  6. 3.2.1 Global Pet Tumor Screening Services Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Pet Tumor Screening Services Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Pet Tumor Screening Services Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Pet Tumor Screening Services Market Size by Regions
  10. 3.3.1 North America Pet Tumor Screening Services Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Pet Tumor Screening Services Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Pet Tumor Screening Services Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Pet Tumor Screening Services Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Pet Tumor Screening Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Pet Tumor Screening Services Industry Trends
  2. 4.2 Pet Tumor Screening Services Industry Drivers
  3. 4.3 Pet Tumor Screening Services Industry Opportunities and Challenges
  4. 4.4 Pet Tumor Screening Services Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Pet Tumor Screening Services Revenue (2021-2026)
  2. 5.2 Global Pet Tumor Screening Services Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Pet Tumor Screening Services Key Company Headquarters & Area Served
  4. 5.4 Global Pet Tumor Screening Services Company, Product Type & Application
  5. 5.5 Global Pet Tumor Screening Services Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Pet Tumor Screening Services Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Pet Tumor Screening Services Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Pet Tumor Screening Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 PetDx
  2. 6.1.1 PetDx Company Information
  3. 6.1.2 PetDx Business Overview
  4. 6.1.3 PetDx Pet Tumor Screening Services Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 PetDx Pet Tumor Screening Services Product Portfolio
  6. 6.1.5 PetDx Recent Developments
  7. 6.2 CYTOGEN
  8. 6.2.1 CYTOGEN Company Information
  9. 6.2.2 CYTOGEN Business Overview
  10. 6.2.3 CYTOGEN Pet Tumor Screening Services Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 CYTOGEN Pet Tumor Screening Services Product Portfolio
  12. 6.2.5 CYTOGEN Recent Developments
  13. 6.3 BioChain
  14. 6.3.1 BioChain Company Information
  15. 6.3.2 BioChain Business Overview
  16. 6.3.3 BioChain Pet Tumor Screening Services Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 BioChain Pet Tumor Screening Services Product Portfolio
  18. 6.3.5 BioChain Recent Developments
  19. 6.4 Small Door
  20. 6.4.1 Small Door Company Information
  21. 6.4.2 Small Door Business Overview
  22. 6.4.3 Small Door Pet Tumor Screening Services Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Small Door Pet Tumor Screening Services Product Portfolio
  24. 6.4.5 Small Door Recent Developments
  25. 6.5 ANGLE
  26. 6.5.1 ANGLE Company Information
  27. 6.5.2 ANGLE Business Overview
  28. 6.5.3 ANGLE Pet Tumor Screening Services Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 ANGLE Pet Tumor Screening Services Product Portfolio
  30. 6.5.5 ANGLE Recent Developments
  31. 6.6 BioChain Institute Inc.
  32. 6.6.1 BioChain Institute Inc. Company Information
  33. 6.6.2 BioChain Institute Inc. Business Overview
  34. 6.6.3 BioChain Institute Inc. Pet Tumor Screening Services Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 BioChain Institute Inc. Pet Tumor Screening Services Product Portfolio
  36. 6.6.5 BioChain Institute Inc. Recent Developments
  37. 6.7 CANCAN DIAGNOSTICS.
  38. 6.7.1 CANCAN DIAGNOSTICS. Company Information
  39. 6.7.2 CANCAN DIAGNOSTICS. Business Overview
  40. 6.7.3 CANCAN DIAGNOSTICS. Pet Tumor Screening Services Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 CANCAN DIAGNOSTICS. Pet Tumor Screening Services Product Portfolio
  42. 6.7.5 CANCAN DIAGNOSTICS. Recent Developments
  43. 6.8 IDEXX Laboratories
  44. 6.8.1 IDEXX Laboratories Company Information
  45. 6.8.2 IDEXX Laboratories Business Overview
  46. 6.8.3 IDEXX Laboratories Pet Tumor Screening Services Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 IDEXX Laboratories Pet Tumor Screening Services Product Portfolio
  48. 6.8.5 IDEXX Laboratories Recent Developments
  49. 6.9 Zoetis
  50. 6.9.1 Zoetis Company Information
  51. 6.9.2 Zoetis Business Overview
  52. 6.9.3 Zoetis Pet Tumor Screening Services Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Zoetis Pet Tumor Screening Services Product Portfolio
  54. 6.9.5 Zoetis Recent Developments
  55. 6.10 VCA Animal Hospitals
  56. 6.10.1 VCA Animal Hospitals Company Information
  57. 6.10.2 VCA Animal Hospitals Business Overview
  58. 6.10.3 VCA Animal Hospitals Pet Tumor Screening Services Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 VCA Animal Hospitals Pet Tumor Screening Services Product Portfolio
  60. 6.10.5 VCA Animal Hospitals Recent Developments
  61. 6.11 AniCura
  62. 6.11.1 AniCura Company Information
  63. 6.11.2 AniCura Business Overview
  64. 6.11.3 AniCura Pet Tumor Screening Services Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 AniCura Pet Tumor Screening Services Product Portfolio
  66. 6.11.5 AniCura Recent Developments
  67. 6.12 Anicom Holdings
  68. 6.12.1 Anicom Holdings Company Information
  69. 6.12.2 Anicom Holdings Business Overview
  70. 6.12.3 Anicom Holdings Pet Tumor Screening Services Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Anicom Holdings Pet Tumor Screening Services Product Portfolio
  72. 6.12.5 Anicom Holdings Recent Developments
  73. 6.13 Tokyo Pet Medical Center
  74. 6.13.1 Tokyo Pet Medical Center Company Information
  75. 6.13.2 Tokyo Pet Medical Center Business Overview
  76. 6.13.3 Tokyo Pet Medical Center Pet Tumor Screening Services Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Tokyo Pet Medical Center Pet Tumor Screening Services Product Portfolio
  78. 6.13.5 Tokyo Pet Medical Center Recent Developments
  79. 6.14 Qiming Pet Hospital
  80. 6.14.1 Qiming Pet Hospital Company Information
  81. 6.14.2 Qiming Pet Hospital Business Overview
  82. 6.14.3 Qiming Pet Hospital Pet Tumor Screening Services Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Qiming Pet Hospital Pet Tumor Screening Services Product Portfolio
  84. 6.14.5 Qiming Pet Hospital Recent Developments
  85. 6.15 RuiPai Pet
  86. 6.15.1 RuiPai Pet Company Information
  87. 6.15.2 RuiPai Pet Business Overview
  88. 6.15.3 RuiPai Pet Pet Tumor Screening Services Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 RuiPai Pet Pet Tumor Screening Services Product Portfolio
  90. 6.15.5 RuiPai Pet Recent Developments
  91. 6.16 IDK Animal Diagnostics
  92. 6.16.1 IDK Animal Diagnostics Company Information
  93. 6.16.2 IDK Animal Diagnostics Business Overview
  94. 6.16.3 IDK Animal Diagnostics Pet Tumor Screening Services Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 IDK Animal Diagnostics Pet Tumor Screening Services Product Portfolio
  96. 6.16.5 IDK Animal Diagnostics Recent Developments
  97. 6.17 Beijing Pet Medical Center
  98. 6.17.1 Beijing Pet Medical Center Company Information
  99. 6.17.2 Beijing Pet Medical Center Business Overview
  100. 6.17.3 Beijing Pet Medical Center Pet Tumor Screening Services Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Beijing Pet Medical Center Pet Tumor Screening Services Product Portfolio
  102. 6.17.5 Beijing Pet Medical Center Recent Developments
  103. 6.18 Baili Pet Health
  104. 6.18.1 Baili Pet Health Company Information
  105. 6.18.2 Baili Pet Health Business Overview
  106. 6.18.3 Baili Pet Health Pet Tumor Screening Services Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Baili Pet Health Pet Tumor Screening Services Product Portfolio
  108. 6.18.5 Baili Pet Health Recent Developments
7 North America
  1. 7.1 North America Pet Tumor Screening Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Pet Tumor Screening Services Market Size by Country (2021-2026)
  3. 7.3 North America Pet Tumor Screening Services Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Pet Tumor Screening Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Pet Tumor Screening Services Market Size by Country (2021-2026)
  3. 8.3 Europe Pet Tumor Screening Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Pet Tumor Screening Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Pet Tumor Screening Services Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Pet Tumor Screening Services Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Pet Tumor Screening Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Pet Tumor Screening Services Market Size by Country (2021-2026)
  3. 10.3 South America Pet Tumor Screening Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Pet Tumor Screening Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Pet Tumor Screening Services Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Pet Tumor Screening Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst